Definium 制药 DFTX
$33.27 +$2.91 (+9.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $33.42 +0.45%
开盘$31.23
昨收$30.36
当日区间$30.91 – $33.42
成交量1.28M
市值$4.47B
市盈率（TTM）–
股息率–
DFTX 相关新闻
匹配 Definium Therapeutics 或代码 DFTX 的头条新闻，按最新排序。
- LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $75
- CCORF Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $64
- LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $78
- Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)
- Stifel Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Raises Target Price to $67 正面
- Maxim Group Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $55
- JonesTrading Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $90
- A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $66 to $91
- RBC Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $66
- A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $50 to $75
- Stifel Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $60
- Wells Fargo Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $72
- BofA Securities Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $75
- BofA Securities Initiates Definium Therapeutics(DFTX.US) With Buy Rating, Announces Target Price $75
- Piper Sandler Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $75
暂无评论——快来第一个聊聊 DFTX。